Although the interaction failed to reach significance, the difference in means between patients with SWEDD+ or PD+ was associated with a moderate effect size (i.e., Cohen's d = 0.55), suggesting that patients with SWEDD+ may be at a greater risk of future cognitive decline than patients with PD+, independent of motor severity.
← all excerpts
Sniffing Out Cognitive Decline in Patients with and without Evidence of Dopaminergic Deficit.
1
—
—